Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000904454-24-000669
Filing Date
2024-12-23
Accepted
2024-12-23 20:26:39
Documents
1
Period of Report
2024-12-19

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3104
  Complete submission text file 0000904454-24-000669.txt   5020
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES, INC. (Reporting) CIK: 0000882095 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35005 | Film No.: 241575396
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address TWO TOWER PLACE 7TH FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address TWO TOWER PLACE 7TH FLOOR SOUTH SAN FRANCISCO CA 94080 (833) 409-4583
ASSEMBLY BIOSCIENCES, INC. (Issuer) CIK: 0001426800 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)